Cargando…
CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review
More powerful prognostic and diagnostic tools are urgently needed for identifying and treating ovarian cancer (OC), which is the most fatal malignancy in women in developed countries. Circular RNAs (circRNAs) are conservative and stable looped molecules that can regulate gene expression by competing...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461915/ https://www.ncbi.nlm.nih.gov/pubmed/34556024 http://dx.doi.org/10.1186/s11658-021-00284-7 |
_version_ | 1784572088134139904 |
---|---|
author | Foruzandeh, Zahra Zeinali-Sehrig, Fatemeh Nejati, Kazem Rahmanpour, Dara Pashazadeh, Fariba Seif, Farhad Alivand, Mohammad Reza |
author_facet | Foruzandeh, Zahra Zeinali-Sehrig, Fatemeh Nejati, Kazem Rahmanpour, Dara Pashazadeh, Fariba Seif, Farhad Alivand, Mohammad Reza |
author_sort | Foruzandeh, Zahra |
collection | PubMed |
description | More powerful prognostic and diagnostic tools are urgently needed for identifying and treating ovarian cancer (OC), which is the most fatal malignancy in women in developed countries. Circular RNAs (circRNAs) are conservative and stable looped molecules that can regulate gene expression by competing with other endogenous microRNA sponges. This discovery provided new insight into novel methods for regulating genes that are involved in many disorders and cancers. This review focuses on the dysregulated expression of circRNAs as well as their diagnostic and prognostic values in OC. We found that studies have identified twenty-one downregulated circRNAs and fifty-seven upregulated ones. The results of these studies confirm that circRNAs might be potent biomarkers with diagnostic, prognostic and therapeutic target value for OC. We also consider the connection between circRNAs and OC cell proliferation, apoptosis, metastasis, and chemotherapy resistance and sensitivity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11658-021-00284-7. |
format | Online Article Text |
id | pubmed-8461915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84619152021-09-24 CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review Foruzandeh, Zahra Zeinali-Sehrig, Fatemeh Nejati, Kazem Rahmanpour, Dara Pashazadeh, Fariba Seif, Farhad Alivand, Mohammad Reza Cell Mol Biol Lett Review Letter More powerful prognostic and diagnostic tools are urgently needed for identifying and treating ovarian cancer (OC), which is the most fatal malignancy in women in developed countries. Circular RNAs (circRNAs) are conservative and stable looped molecules that can regulate gene expression by competing with other endogenous microRNA sponges. This discovery provided new insight into novel methods for regulating genes that are involved in many disorders and cancers. This review focuses on the dysregulated expression of circRNAs as well as their diagnostic and prognostic values in OC. We found that studies have identified twenty-one downregulated circRNAs and fifty-seven upregulated ones. The results of these studies confirm that circRNAs might be potent biomarkers with diagnostic, prognostic and therapeutic target value for OC. We also consider the connection between circRNAs and OC cell proliferation, apoptosis, metastasis, and chemotherapy resistance and sensitivity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11658-021-00284-7. BioMed Central 2021-09-23 /pmc/articles/PMC8461915/ /pubmed/34556024 http://dx.doi.org/10.1186/s11658-021-00284-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Letter Foruzandeh, Zahra Zeinali-Sehrig, Fatemeh Nejati, Kazem Rahmanpour, Dara Pashazadeh, Fariba Seif, Farhad Alivand, Mohammad Reza CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review |
title | CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review |
title_full | CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review |
title_fullStr | CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review |
title_full_unstemmed | CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review |
title_short | CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review |
title_sort | circrnas as potent biomarkers in ovarian cancer: a systematic scoping review |
topic | Review Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461915/ https://www.ncbi.nlm.nih.gov/pubmed/34556024 http://dx.doi.org/10.1186/s11658-021-00284-7 |
work_keys_str_mv | AT foruzandehzahra circrnasaspotentbiomarkersinovariancancerasystematicscopingreview AT zeinalisehrigfatemeh circrnasaspotentbiomarkersinovariancancerasystematicscopingreview AT nejatikazem circrnasaspotentbiomarkersinovariancancerasystematicscopingreview AT rahmanpourdara circrnasaspotentbiomarkersinovariancancerasystematicscopingreview AT pashazadehfariba circrnasaspotentbiomarkersinovariancancerasystematicscopingreview AT seiffarhad circrnasaspotentbiomarkersinovariancancerasystematicscopingreview AT alivandmohammadreza circrnasaspotentbiomarkersinovariancancerasystematicscopingreview |